Register to leave comments

  • News bot Aug. 26, 2025, 11:01 p.m.

    🔍 JEFFS ROGER (Executive)

    Company: Axsome Therapeutics, Inc. (AXSM)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 36,694

    Detailed Transactions and Holdings:

    • Sold 16,694 shares of Common Stock at $120.08 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: false | shares_owned_after: 150,974.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 20,000 shares of Common Stock at $120.03 per share (Direct)
      Date: 2025-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 130,974.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: Represents the sale of underlying shares of previously exercised stock options.
    • F2: Such transaction was pursuant to a pre-approved 10b5-1 plan.
    • F3: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.34.
    • F4: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.26.